StockGlow

Hansa Biopharma AB (publ) (0RC7.IL)

Hansa Biopharma AB (publ), a biopharmaceutical company, engages in development and commercialization of treatments with rare immunological conditions using its proprietary enzyme technology platform.

34.72+0.00%Healthcare
Compare 0RC7.IL with
StockGlow Score
76
Leaning Bullish
BearishBullish
1 year ago+22.6%

The outlook

Hansa Biopharma AB (publ) currently reads as leaning bullish based on above its 50- & 200-day averages, 58% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendAbove its 50- & 200-day averages
52-week range58% of the way from its 52-week low to high
Market cap
$49.4M
52-wk high
42.96
52-wk low
23.57
50-day avg
33.59
200-day avg
32.10
Trailing P/E
—

Similar stocks

0JXZ.ILLakefront Biotherapeutics NV$24.32+1.54%0NM7.ILVirbac SA$340.50-0.44%0KBS.ILRecordati Industria Chimica e Farmaceutica S.p.A.$51.45+0.15%0M2O.ILOrion Oyj$81.55+0.74%2L9.FVisionWave Holdings, Inc.$1.63-3.66%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy